Literature DB >> 30321090

Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression?

Lucía Angélica Méndez-García1, Karen Elizabeth Nava-Castro2, Tania de Lourdes Ochoa-Mercado3, Margarita Isabel Palacios-Arreola2, Rocío Alejandra Ruiz-Manzano3, Mariana Segovia-Mendoza3, Helena Solleiro-Villavicencio4, Cinthia Cázarez-Martínez2, Jorge Morales-Montor3.   

Abstract

In breast cancer, an uncontrolled cell proliferation leads to tumor formation and development of a multifactorial disease. Metastasis is a complex process that involves tumor spread to distant parts of the body from its original site. Metastatic dissemination represents the main physiopathology of cancer. Inter- and intracellular communication in all systems in vertebrates is mediated by cytokines, which are highly inducible, secretory proteins, produced not only by immune system cells, but also by endocrine and nervous system cells. It has become clear in recent years that cytokines, as well as their receptors are produced in the organisms under physiological and pathological conditions; recently, they have been closely related to breast cancer metastasis. The exact initiation process of breast cancer metastasis is unknown, although several hypotheses have emerged. In this study, we thoroughly reviewed the role of several cytokines in breast cancer metastasis. Data reviewed suggest that cytokines and growth factors are key players in the breast cancer metastasis induction. This knowledge must be considered with the aim to development of new therapeutic approaches to counter breast cancer metastasis.

Entities:  

Keywords:  breast cancer; cytokines; metastasis; metastasis development; metastasis progression

Mesh:

Substances:

Year:  2018        PMID: 30321090     DOI: 10.1089/jir.2018.0024

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  14 in total

Review 1.  Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.

Authors:  Meng Lan; Wenping Lu; Tengteng Zou; Lihong Li; Fengjie Liu; Tiange Cai; Yu Cai
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

2.  DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.

Authors:  Hitesh Vasiyani; Minal Mane; Khushboo Rana; Anjali Shinde; Milton Roy; Jyoti Singh; Dhruv Gohel; Fatema Currim; Ratika Srivastava; Rajesh Singh
Journal:  Apoptosis       Date:  2022-08-26       Impact factor: 5.561

3.  Modeling cancer immunoediting in tumor microenvironment with system characterization through the ising-model Hamiltonian.

Authors:  Alfonso Rojas-Domínguez; Renato Arroyo-Duarte; Fernando Rincón-Vieyra; Matías Alvarado-Mentado
Journal:  BMC Bioinformatics       Date:  2022-05-30       Impact factor: 3.307

4.  Identification of a 5-gene-risk score model for predicting luminal A-invasive lobular breast cancer survival.

Authors:  Yi-Huan Chen; Tao-Feng Zhang; Yi-Yuan Liu; Jie-Hua Zheng; Wei-Xun Lin; Yao-Kun Chen; Jie-Hui Cai; Juan Zou; Zhi-Yang Li
Journal:  Genetica       Date:  2022-05-10       Impact factor: 1.633

Review 5.  Notch-Inflammation Networks in Regulation of Breast Cancer Progression.

Authors:  Yulia Liubomirski; Adit Ben-Baruch
Journal:  Cells       Date:  2020-06-28       Impact factor: 6.600

6.  Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.

Authors:  Citrawati Dyah Kencono Wungu; Fis Citra Ariyanto; Gwenny Ichsan Prabowo; Retno Handajani
Journal:  BMC Cancer       Date:  2020-11-23       Impact factor: 4.430

7.  Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling.

Authors:  Hui Shi; Luping Zhao; Xinlin Guo; Runping Fang; Hui Zhang; Guanjun Dong; Jia Fu; Fenglian Yan; Junfeng Zhang; Zhaochen Ning; Qun Ma; Zhihua Li; Chunxia Li; Jun Dai; Chuanping Si; Huabao Xiong
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

8.  S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis.

Authors:  Alamelu G Bharadwaj; Margaret L Dahn; Rong-Zong Liu; Patricia Colp; Lynn N Thomas; Ryan W Holloway; Paola A Marignani; Catherine Kl Too; Penelope J Barnes; Rosaline Godbout; Paola Marcato; David M Waisman
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

9.  NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells.

Authors:  Emma H Doud; Trupti Shetty; Melissa Abt; Amber L Mosley; Timothy W Corson; Anand Mehta; Elizabeth S Yeh
Journal:  Biomedicines       Date:  2020-12-12

10.  Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.

Authors:  Peramaiyan Rajendran; Rebai Ben Ammar; Fatma J Al-Saeedi; Maged Elsayed Mohamed; Mih Islam; Saeed Y Al-Ramadan
Journal:  J Cell Mol Med       Date:  2020-11-07       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.